You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AMLX Sale Disclosure
Milne George M Jr · SEC Form 4 · Filed Oct 7, 2026
Sale
Calculated transaction value
$830.9K
Milne George M Jr Director
AMLX
Transaction date
Oct 5, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed 2 days later
AMLX daily price context
Close on/before transaction
$27.78
Oct 5, 2026
First close after public filing
$27.2
Oct 8, 2026
30-day return after filing
+8.46%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 30,000 shares @ $27.7
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-416950
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$830.9K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. AMLX Current | Sale | Oct 5, 2026 | $830.9K |